A new link in ovarian cancer angiogenesis: lysophosphatidic acid and vascular endothelial growth factor expression.
Folkman
J
J
D020533:Angiogenesis Inhibitors / Q000494:pharmacology; D000818:Animals; D016228:Endothelial Growth Factors / Q000096:biosynthesis*; D005260:Female; D006801:Humans; D008222:Lymphokines / Q000096:biosynthesis*; D008246:Lysophospholipids / Q000096:biosynthesis*; D051379:Mice; D009389:Neovascularization, Pathologic / Q000473:pathology*; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000473:pathology*; D010641:Phenotype; D011485:Protein Binding; D011956:Receptors, Cell Surface / Q000378:metabolism; D043562:Receptors, G-Protein-Coupled; D049368:Receptors, Lysophosphatidic Acid; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D020533:Angiogenesis Inhibitors; D016228:Endothelial Growth Factors; D008222:Lymphokines; D008246:Lysophospholipids; D011956:Receptors, Cell Surface; D043562:Receptors, G-Protein-Coupled; D049368:Receptors, Lysophosphatidic Acid; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors